SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 260 filers reported holding SAGE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $577,104 | -35.5% | 28,042 | +47.5% | 0.04% | -37.3% |
Q2 2023 | $894,179 | +52.2% | 19,017 | +35.8% | 0.06% | +68.6% |
Q1 2023 | $587,440 | +28.1% | 14,000 | +16.5% | 0.04% | +45.8% |
Q4 2022 | $458,519 | -53.4% | 12,022 | -52.1% | 0.02% | -31.4% |
Q3 2022 | $983,000 | +21.8% | 25,106 | +0.5% | 0.04% | +52.2% |
Q2 2022 | $807,000 | +143.8% | 24,973 | +149.8% | 0.02% | +130.0% |
Q1 2022 | $331,000 | +21.2% | 9,997 | +107.8% | 0.01% | +25.0% |
Q2 2021 | $273,000 | -58.3% | 4,812 | -36.5% | 0.01% | -52.9% |
Q4 2020 | $655,000 | +87.7% | 7,574 | +32.7% | 0.02% | 0.0% |
Q3 2020 | $349,000 | -1.4% | 5,708 | -32.9% | 0.02% | -10.5% |
Q2 2020 | $354,000 | -73.3% | 8,502 | -53.7% | 0.02% | -62.0% |
Q4 2019 | $1,327,000 | -39.0% | 18,381 | +18.5% | 0.05% | -49.0% |
Q3 2019 | $2,176,000 | -8.5% | 15,511 | +19.4% | 0.10% | -16.2% |
Q2 2019 | $2,379,000 | +825.7% | 12,992 | +614.6% | 0.12% | +680.0% |
Q3 2018 | $257,000 | -46.1% | 1,818 | -40.4% | 0.02% | -50.0% |
Q2 2018 | $477,000 | -2.9% | 3,049 | -0.1% | 0.03% | -16.7% |
Q1 2018 | $491,000 | -21.9% | 3,051 | -20.1% | 0.04% | -29.4% |
Q4 2017 | $629,000 | +159.9% | 3,820 | -1.5% | 0.05% | +131.8% |
Q3 2017 | $242,000 | -40.0% | 3,880 | -23.3% | 0.02% | -42.1% |
Q2 2017 | $403,000 | +11.9% | 5,060 | 0.0% | 0.04% | +11.8% |
Q1 2017 | $360,000 | +44.0% | 5,060 | +3.2% | 0.03% | +13.3% |
Q4 2016 | $250,000 | – | 4,901 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
RA Capital Management | 455,173 | $74,972,000 | 6.27% |
Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |